Skip to search formSkip to main contentSkip to account menu

4-anilidopiperidine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2012
Highly Cited
2012
SummarySynopsisFentanyl is a synthetic opioid with short-acting analgesic activity after intravenous or subcutaneous… 
Review
2012
Review
2012
SummaryAbstractRemifentanil (Ultiva™), a 4-anilidopiperidine derivative of fentanyl, is an ultra-short-acting μ-opioid receptor… 
Review
2003
Review
2003
Remifentanil is a 4-anilidopiperidine mu-opioid analgesic which is rapidly metabolized by unspecific blood and tissue esterases… 
1998
1998
Fentanyl, and its structural analogs lofentanil and sufentanil, are potent analgesics used clinically in the management of pain… 
Review
1995
Review
1995
SummaryRemifentanil is a novel, short-acting μ-receptor opioid agonist currently in the late stages of development. A member of… 
Highly Cited
1991
Highly Cited
1991
In an effort to discover a potent ultrashort-acting mu opioid analgetic that is capable of metabolizing to an inactive species… 
1984
1984
Conformational flexibility of the N-acyl portion of fentanyl-type analgetics was restricted through the synthesis of novel… 
1979
1979
Relatively little information is available concerning the influence of conformational factors on the potent analgesic actions of… 
1973
1973
Abstract: In view of the potency-enhancing effect of methyl substitution of the piperidine ring of the 4-phenylpiperidine…